Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Greenland Mines Ltd issued 34,551,939 shares of common stock of common stock to the Purchasers for aggregate gross proceeds of approximately $7,750,000.
- Security
- common stock
- Shares
- 34,551,939 shares of common stock
- Purchaser
- the Purchasers
- Consideration
- aggregate gross proceeds of approximately $7,750,000
Exact text from the filing
On March 2, 2026, Klotho Neurosciences, Inc. (the “Company”) closed and completed the private placement (the “Financing”) contemplated by that certain Securities Purchase Agreement, dated February 19, 2026, by and among the Company and the purchasers named therein (the “Purchasers”). A copy of the Securities Purchase Agreement is included as Exhibit 10.1 to the Company’s Form 8-K filed on February 24, 2026. At the closing of the Offering, the Company issued to the Purchasers an aggregate of 34,551,939 shares of the Company’s common stock and warrants to purchase up to an aggregate of 34,551,939 shares of Common Stock (the “Warrants”).The sale of the securities resulted in aggregate gross proceeds to the Company of approximately $7,750,000.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Greenland Mines Ltd issued warrants to purchase up to 34,551,939 shares of common stock of warrant to the Purchasers for aggregate gross proceeds of approximately $7,750,000 (included in the same private placement).
- Security
- warrant
- Shares
- warrants to purchase up to 34,551,939 shares of common stock
- Purchaser
- the Purchasers
- Consideration
- aggregate gross proceeds of approximately $7,750,000 (included in the same private placement)
Exact text from the filing
On March 2, 2026, Klotho Neurosciences, Inc. (the “Company”) closed and completed the private placement (the “Financing”) contemplated by that certain Securities Purchase Agreement, dated February 19, 2026, by and among the Company and the purchasers named therein (the “Purchasers”). A copy of the Securities Purchase Agreement is included as Exhibit 10.1 to the Company’s Form 8-K filed on February 24, 2026. At the closing of the Offering, the Company issued to the Purchasers an aggregate of 34,551,939 shares of the Company’s common stock and warrants to purchase up to an aggregate of 34,551,939 shares of Common Stock (the “Warrants”).The sale of the securities resulted in aggregate gross proceeds to the Company of approximately $7,750,000.
View on SEC.gov